Abstract:Background: Radiation therapy is an important cancer treatment modality in both adjuvant and definitive setting, however, the use of radiation therapy for elective treatment of regional lymph nodes is controversial for pancreatic cancer. No consensus on proper selection and delineation of subclinical lymph nodal areas in adjuvant or definitive radiation therapy has been suggested either conclusively or proposed for further investigation. This analysis aims to study the pattern of lymph node metastasis through a pooled analysis of published results after radical tumor and lymph nodal resection with histological study in pancreatic cancer.Methods: Literature search using electronic databases including MEDLINE, EMBASE, and CANCERLIT from January 1970 to June 2009 was performed, supplemented by review of references. Eighteen original researches and a total of 5954 pancreatic cancer patients underwent radical surgical resection were included in this analysis. The probability of metastasis in regional lymph nodal stations (using Japan Pancreas Society [JPS] Classification) was calculated and analyzed based on the location and other characteristics of the primary disease.Results: Commonly involved nodal regions in patients with pancreatic head tumor include lymph nodes around the common hepatic artery (Group 8, 9.79%), posterior pancreaticoduodenal lymph nodes (Group 13, 32.31%), lymph nodes around the superior mesenteric artery (Group 14, 15.85%), paraaortic lymph nodes (Group 16, 10.92%), and anterior pancreaticoduodenal lymph nodes (Group 17, 19.78%); The probability of metastasis in other lymph nodal regions were <9%. Commonly involved nodal regions in patients with pancreatic body/tail tumor include lymph nodes around the common hepatic artery (Group 8, 15.07%), lymph nodes around the celiac trunk (Group 9, 9.59%), lymph nodes along the splenic artery (Group 11, 35.62%), lymph nodes around the superior mesenteric artery (Group 14, 9.59%), paraaortic lymph nodes (Group 16, 16.44%), and inferior body lymph nodes (Group 18, 24.66%). The probability of metastasis in other lymph nodal regions were <9%.Conclusions: Pancreatic cancer has a high propensity of regional lymphatic metastases; however, clear patterns including the site and probability of metastasis can be identified and used as a guide of treatment in patients with resectable pancreatic cancer. Further clinical investigation is needed to study the efficacy of elective treatment to CTV defined based on these patterns using high-dose conformal or intensity-modulated radiation therapy.

Extent and Ideas about Regional Lymphadenectomy for Pancreatic Head Carcinoma

Total Mesopancreas Excision in Radical Resection of Pancreatic Head Carcinoma

Extent and Disputes about Radical Resection for Pancreatic Head Carcinoma

The role of vascular resection and reconstruction in pancreaticoduodenectomy

The feasibility of surgical resection for carcinoma of the head of pancreas with major vascular invasion

Extended Radical Operation of Pancreatic Head Cancer: Appraisal of Its Clinical Significance

[The progression of the extent of lymph node dissection in radical resection of pancreatic head cancer]

Extended Lymph Node Dissection for Pancreatic Head Carcinoma: Controversy and Update

Should a Standard Lymphadenectomy During Pancreatoduodenectomy Exclude Para-Aortic Lymph Nodes for All Cases of Resectable Pancreatic Head Cancer? A Consensus Statement by the Chinese Study Group for Pancreatic Cancer (CSPAC).

Highlights and difficulties in surgical treatment for pancreatic carcinoma

The Characteristics of Lymph Node Metastasis in Pancreatic Head Cancer

Consensus and controversy on the radical resection range of pancreatic cancer

Role of Regional Lymphadenectomy in Different Stage of Gallbladder Carcinoma

Features of Lymph Node Metastasis in 50 Cases of Pancreatic Ductal Adenoma in the Head

Lymphadenectomy for Adenocarcinoma of the Pancreatic Head

An Outlook on the Lymph Nodes Dissection During the Pancreatectomy for Pancreatic Cancer

Pathologic analysis of lymph node involvement in carcinoma of head of pancreas

Effects of Preoperative Regional Intra-Arterial Chemotherapy on Lymphatic Metastasis of Pancreatic Head Carcinoma

Proposing the Lymphatic Target Volume for Elective Radiation Therapy for Pancreatic Cancer: a Pooled Analysis of Clinical Evidence

The Necessity of Dissection of No. 14 Lymph Nodes to Patients With Pancreatic Ductal Adenocarcinoma Based on the Embryonic Development of the Head of the Pancreas.

New advances in the treatment of pancreatic carcinoma